Tirzepatide 20mg

Tirzepatide is an innovative dual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, designed to deliver comprehensive metabolic benefits. Approved for the treatment of type 2 diabetes and chronic weight management in adults with obesity or overweight and related comorbidities, Tirzepatide mimics the effects of two key incretin hormones, GIP and GLP-1. These hormones are essential for regulating glucose levels and appetite, allowing Tirzepatide to provide superior glycemic control and significant weight reduction through its dual-action mechanism.